Loading...
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)
BACKGROUND: Riluzole is approved for the treatment of amyotrophic lateral sclerosis in most countries. Questions persist about its clinical utility because of high cost and modest efficacy. OBJECTIVES: To examine the efficacy of riluzole in prolonging survival and in delaying the use of surrogates (...
Na minha lista:
| Udgivet i: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley & Sons, Ltd
2012
|
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7055506/ https://ncbi.nlm.nih.gov/pubmed/22419278 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD001447.pub3 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|